Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) Shares Outstanding (Diluted Average) (2017 - 2023)

Historic Shares Outstanding (Diluted Average) for Mesa Laboratories (MLAB) over the last 11 years, with Q4 2023 value amounting to $5.4 million.

  • Mesa Laboratories' Shares Outstanding (Diluted Average) rose 67.16% to $5.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.4 million, marking a year-over-year increase of 67.16%. This contributed to the annual value of $3.6 million for FY2015, which is 108.0% up from last year.
  • Per Mesa Laboratories' latest filing, its Shares Outstanding (Diluted Average) stood at $5.4 million for Q4 2023, which was up 67.16% from $5.4 million recorded in Q3 2023.
  • In the past 5 years, Mesa Laboratories' Shares Outstanding (Diluted Average) registered a high of $5.4 million during Q4 2023, and its lowest value of $5.3 million during Q4 2021.
  • For the 3-year period, Mesa Laboratories' Shares Outstanding (Diluted Average) averaged around $5.4 million, with its median value being $5.4 million (2022).
  • As far as peak fluctuations go, Mesa Laboratories' Shares Outstanding (Diluted Average) soared by 37.43% in 2022, and later surged by 67.16% in 2023.
  • Mesa Laboratories' Shares Outstanding (Diluted Average) (Quarter) stood at $5.3 million in 2021, then increased by 0.51% to $5.4 million in 2022, then grew by 0.67% to $5.4 million in 2023.
  • Its Shares Outstanding (Diluted Average) was $5.4 million in Q4 2023, compared to $5.4 million in Q3 2023 and $5.4 million in Q4 2022.